undamentalytics Newsletter
Sign in

Natural Alternatives International Inc revenue

Natural Alternatives International Inc's revenue was $143m in fiscal 2026, up 9.7% on the year before. Since fiscal 2011 ($55.9m) it has grown at a compound 6.4% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026
Revenue5673637480114122132138119179171154114130143
Growth on the year before—+30.3%−13.8%+17.7%+7.5%+43.6%+6.8%+8.6%+4.4%−14.0%+50.2%−4.2%−9.9%−26.1%+14.1%+9.7%
Gross profit11151213142526262419303118799

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to June 30, 2026
Segments
Line of business Revenue Share YoY
Private Label Contract Manufacturing $135M 94.5% ▲ 10.5%
Patent and Trademark Licensing $7.9M 5.5% ▼ 2.2%
Geography
Region Revenue Share YoY
United States $93.3M 65.5% ▲ 17.9%
Outside the US $49.2M 34.5% ▼ 3.0%

From Natural Alternatives International Inc's 10-K filed September 28, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Natural Alternatives International Inc $143m 9.7% -2.6%
Zevra Therapeutics, Inc. $136m 119.4% 101.9%
Heron Therapeutics, Inc. $151m 1.0% 8.6%
Niagen Bioscience, Inc. $129m 11.0% 16.8%
Amarin Corp plc\uk $176m -22.3% -18.3%
Cronos Group Inc. $179m 37.5% 30.3%

Compare with peers

Head to head: NAII vs ZVRAHRTX vs NAIINAGE vs NAII

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Natural Alternatives International Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Natural Alternatives International Inc.